Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Benefits and Harms of Cannabis Use in Patients Treated With Immunotherapy for Cancer: a Prospective Cohort Study

NCT06206941 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT06206941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06206941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Benefits and Harms of Cannabis Use in Patients Treated With Immunotherapy for Cancer: a Prospective Cohort Study
Lead sponsor
State University of New York at Buffalo
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2025
Completion date
December 31, 2027
Enrollment
450 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer